Page 5 - Polarityte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Polarityte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Polarityte Today - Breaking & Trending Today

PolarityTE, Inc. (NASDAQ:PTE) Short Interest Down 95.6% in May

PolarityTE, Inc. (NASDAQ:PTE – Get Rating) saw a large decline in short interest in May. As of May 15th, there was short interest totalling 60,200 shares, a decline of 95.6% from the April 30th total of 1,380,000 shares. Based on an average daily volume of 323,600 shares, the days-to-cover ratio is presently 0.2 days. Currently, […] ....

United States , First Republic Investment Management Inc , Polarityte Inc , Contract Services , Renaissance Technologies , De Shaw Co , Polarityte Company Profile Get Rating , Bernardo Wealth Planning , Cantor Fitzgerald , Get Rating , Republic Investment Management , Wealth Planning , Regenerative Medicine Products , Nasdaq Pte ,

PolarityTE to Effectuate 1-for-25 Reverse Stock Split

/PRNewswire/ PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today announced that the. ....

United States , Salt Lake City , Prnewswire Polarityte Inc , Company Annual , Polarityte Inc , Drug Administration , Nasdaq Capital Market , Securities Purchase Agreement , Nasdaq Capital , Private Securities Litigation Reform Act , Annual Reports ,

PolarityTE Inc. Q1 Loss Increases, misses estimates

WASHINGTON (dpa-AFX) - PolarityTE Inc. (PTE) revealed Loss for first quarter that decreased from last year but missed the Street estimates.The company's bottom line totaled -$3.77 million, or -$0.09 ....

United States , Thomson Reuters , Polarityte Inc , Analyst Estimates ,

PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®

/PRNewswire/ PolarityTE, Inc. (Nasdaq: PTE) today announced that the U.S. Food and Drug Administration (FDA) granted a Regenerative Medicine Advanced. ....

Salt Lake City , United States , Richard Hague , Prnewswire Polarityte Inc , Company Annual , Polarityte Inc , Drug Administration , Regenerative Medicine Advanced Therapy , Century Cures Act , Breakthrough Therapy , Chief Executive Officer , Private Securities Litigation Reform Act , Annual Reports ,

PolarityTE: FDA Grants RMAT Designation For SkinTE

WASHINGTON (dpa-AFX) - PolarityTE, Inc. (PTE) announced the FDA granted a Regenerative Medicine Advanced Therapy designation to SkinTE. RMAT designation is a dedicated program designed to expedite ....

United States , Richard Hague , Polarityte Inc , Regenerative Medicine Advanced Therapy ,